Grandjean Lapierre, Simon

M.D., MSc., FRCPC

Principal scientist

Centre de recherche du CHUM

Research theme

Medical microbiologist
Laboratory medicine Department, CHUM

Internist & Infectious diseases specialist
Department of medicine, CHUM

Assistant professor
Department of microbiology, infectiology and immunology, Université de Montréal

Contact

simon.grandjean-lapierre.chum@ssss.gouv.qc.ca
514 890-8000, ext. 36210

> LinkedIn
> Twitter
> YouTube

The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.

Other affiliations

Affiliate researcher
Institut Pasteur de Madagascar

McGill International TB Center

Keywords

Tuberculosis, molecular epidemiology, methods development, global health and technology, eHealth.

Research interests

Dr. Grandjean Lapierre leads a translational research program focused on Tuberculosis control in Canada and abroad, notably in Madagascar. His research activities principally include the impact assessment of new innovative technologies and molecular diagnostic tools.

Molecular diagnostics

  • Methods development for rapid sequencing from primary clinical samples
  • Molecular epidemiology and impact on disease transmission 

Innovative technologies

  • Digital cough monitoring and acoustic epidemiology
  • Drones for health programs delivery

Publications

Publications indexed on PubMed

Publications indexed on ORCID

https://pubmed.ncbi.nlm.nih.gov/32600414/
Grandjean Lapierre, S., Knoblauch, A.M., Randriamanana, D. et al. Multidrug-resistant tuberculosis surveillance and cascade of care in Madagascar: a five-year (2012–2017) retrospective study. BMC Med 18, 173 (2020). https://doi.org/10.1186/s12916-020-01626-6

https://pubmed.ncbi.nlm.nih.gov/32055708/
Hunt M, Bradley P, Lapierre SG et al. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe [version 1; peer review: 2 approved, 1 approved with reservations]. Wellcome Open Res 2019, 4:191 (https://doi.org/10.12688/wellcomeopenres.15603.1)

https://pubmed.ncbi.nlm.nih.gov/31221109/
Rakotosamimanana, N., Lapierre, S.G., Raharimanga, V. et al. Performance and impact of GeneXpert MTB/RIF® and Loopamp MTBC Detection Kit® assays on tuberculosis case detection in Madagascar. BMC Infect Dis 19, 542 (2019). https://doi.org/10.1186/s12879-019-4198-6

https://pubmed.ncbi.nlm.nih.gov/32634140/
Bahrainwala L, Knoblauch AM, Andriamiadanarivo A, Diab MM, McKinney J, Small PM, Lapierre, S.G.et al. (2020) Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis. PLoS ONE 15(7): e0235572. https://doi.org/10.1371/journal.pone.0235572

https://pubmed.ncbi.nlm.nih.gov/31076475/
Nouvet E, Knoblauch AM, Passe I, Lapierre, S.G.et al. Perceptions of drones, digital adherence monitoring technologies and educational videos for tuberculosis control in remote Madagascar: a mixed-method study protocol BMJ Open 2019;9:e028073. doi: 10.1136/bmjopen-2018-028073

News

Les drones peuvent-ils améliorer la santé de populations isolées? (In French only)